WITHDRAWN: Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systematic review and meta-analysis

Anthéa Bertrand; Denis Gallot; Bruno Pereira; Amélie Delabaere; Amélie Delabaere; Anthéa Bertrand; Denis Gallot; Igor Tauveron; Marion Rouzaire; Bruno Pereira

Current Research in Pharmacology and Drug Discovery (Jan 2023)

WITHDRAWN: Myoinositol supplementation for the prevention of gestational diabetes in at-risk patients. Systematic review and meta-analysis

Anthéa Bertrand,
Denis Gallot,
Bruno Pereira,
Amélie Delabaere,
Amélie Delabaere,
Anthéa Bertrand,
Denis Gallot,
Igor Tauveron,
Marion Rouzaire,
Bruno Pereira

Affiliations

Anthéa Bertrand: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France
Denis Gallot: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France; Equipe, ''Translationnal Approach to Epithelial Injury and Repair'', Université Clermont Auvergne, CNRS, Inserm, GReD, F-63000, Clermont-Ferrand, France
Bruno Pereira: CHU Clermont-Ferrand, Biostatistics Unit (DRCI) Department, Clermont-ferrand, France
Amélie Delabaere: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France; Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000, Clermont-Ferrand, France; Corresponding author. Obstetrics Department University Hospital of Clermont-Ferand 1, place Lucie et Raymond AUBRAC, 63100, Clermont-Ferrand, France.
Amélie Delabaere: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France; Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, F-63000, Clermont-Ferrand, France
Anthéa Bertrand: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France
Denis Gallot: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France; Equipe, ''Translationnal Approach to Epithelial Injury and Repair'', Université Clermont Auvergne, CNRS, Inserm, GReD, F-63000, Clermont-Ferrand, France
Igor Tauveron: Endocrinology Diabetology and Metabolic Diseases, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, F-63000 Clermont-Ferrand, France; Institut Génétique, Reproduction & Développement (iGReD), CNRS, INSERM, University of Clermont, Auvergne, F-63000 Clermont-Ferrand, France
Marion Rouzaire: CHU Clermont-Ferrand, Pôle Femme Et Enfant, 1 Place Lucie et Raymond Aubrac 63003 CLERMONT-FERRAND Cedex 1, France
Bruno Pereira: CHU Clermont-Ferrand, Biostatistics Unit (DRCI) Department, Clermont-ferrand, France

Journal volume & issue: Vol. 4
p. 100140

Abstract

Read online

This article has been withdrawn: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).This article has been withdrawn at the request of Author.The publisher apologizes to the readers for this unfortunate error.

Published in Current Research in Pharmacology and Drug Discovery

ISSN: 2590-2571 (Online)
Publisher: Elsevier
Country of publisher: Netherlands
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://www.journals.elsevier.com/current-research-in-pharmacology-and-drug-discovery/

About the journal